Cargando…

Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)

This multicenter retrospective cohort study compared the effectiveness and safety of long-term tafluprost, travoprost, or latanoprost in patients with primary open-angle glaucoma (POAG) or normal-tension glaucoma (NTG). Data were extracted from electronic medical records of 300 patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Joon-Mo, Sung, Kyung-Rim, Kim, Hwang-Ki, Park, Sang-Woo, Lee, Eun-Ji, Jeoung, Jin-Wook, Park, Hae-Young Lopilly, Ahn, Jaehong, Yoo, Chungkwon, Kim, Chan-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235659/ https://www.ncbi.nlm.nih.gov/pubmed/34205421 http://dx.doi.org/10.3390/jcm10122717

Ejemplares similares

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
por: El Hajj Moussa, Wissam Georges, et al.
Publicado: (2018)

Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost
por: Sacchi, Matteo, et al.
Publicado: (2014)

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients
por: Cai, Ziyan, et al.
Publicado: (2021)

Peripapillary Vessel Density in Young Patients with Open-Angle Glaucoma: Comparison between High-Tension and Normal-Tension Glaucoma
por: Park, Ji-Hye, et al.
Publicado: (2019)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2012)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda, Yoko, et al.
Publicado: (2016)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
por: Igarashi, Ryoko, et al.
Publicado: (2014)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold, Leonard K, et al.
Publicado: (2014)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Lafuma, Antoine, et al.
Publicado: (2011)

Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007)

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients
por: Nomura, Akio, et al.
Publicado: (2018)

Comparison of the Safety and Efficacy between Preserved and Preservative-Free Latanoprost and Preservative-Free Tafluprost
por: Kim, Joon Mo, et al.
Publicado: (2021)

Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
por: Schnober, Dietmar, et al.
Publicado: (2010)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Nomura, Yuya, et al.
Publicado: (2010)

Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial
por: Lee, Na Young, et al.
Publicado: (2016)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2013)

A 1-Year Randomized Study of the Clinical and Confocal Effects of Tafluprost and Latanoprost in Newly Diagnosed Glaucoma Patients
por: Fogagnolo, Paolo, et al.
Publicado: (2015)

Predicting the development of normal tension glaucoma and related risk factors in normal tension glaucoma suspects
por: Park, Hae-Young Lopilly, et al.
Publicado: (2021)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
por: Godfrey, David A, et al.
Publicado: (2009)

Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
por: Mishra, Deepak, et al.
Publicado: (2014)

Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
por: Hagras, Sherein M, et al.
Publicado: (2021)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Katz, Gregory, et al.
Publicado: (2010)

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo, Julian, et al.
Publicado: (2016)

Optic disc melanocytoma with normal tension glaucoma and angle closure glaucoma: Two case reports
por: Kim, Dae Sung, et al.
Publicado: (2020)

Latanoprost in the treatment of glaucoma
por: Alm, Albert
Publicado: (2014)

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011)

Efficacy of travoprost for the treatment of patients with glaucoma
por: Zhang, Xiu-Li, et al.
Publicado: (2019)

Macular Blood Flow and Pattern Electroretinogram in Normal Tension Glaucoma
por: Jeon, Soo Ji, et al.
Publicado: (2022)

Characteristics of Normal-tension Glaucoma Patients with Temporal Retinal Nerve Fibre Defects
por: Yum, Hae Ri, et al.
Publicado: (2020)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2012)

Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016)

Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration Hospital
por: Farris, Edmund P
Publicado: (2008)

Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2018)

Posterior scleral deformation and autonomic dysfunction in normal tension glaucoma
por: Shin, Da Young, et al.
Publicado: (2020)

Comparison of Prelaminar Thickness between Primary Open Angle Glaucoma and Normal Tension Glaucoma Patients
por: Jung, Youn Hea, et al.
Publicado: (2015)

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
por: Lopes, Joao F., et al.
Publicado: (2015)

Normal-tension Glaucoma Management: A Survey of Glaucoma Sub-specialists in Korea
por: Han, Young Soo, et al.
Publicado: (2020)

Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
por: Hwang, Young Hoon
Publicado: (2014)

Influence of the lamina cribrosa on the rate of global and localized retinal nerve fiber layer thinning in open-angle glaucoma
por: Park, Hae-Young Lopilly, et al.
Publicado: (2017)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
por: Liu, Yang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1qo98kimbonjden9r5hr7sbem4